At least $9,890 in Medicaid payments went to services coded specifically for COVID-19 in Cadillac in 2024, based on data from the U.S. Department of Health and Human Services Medicaid Provider Spending database.
Medicaid, a state-administered program funded jointly by state and federal governments, provides coverage for low-income individuals, families, seniors, children, and people with disabilities—making it a major component of the U.S. health care system.
Because taxpayer dollars support Medicaid, changes in local claim amounts reflect how public health resources are distributed within a community.
This analysis defined COVID-19–related services as those billed with HCPCS codes identified as “COVID-19” or “coronavirus”-related in billing information or reference data. These figures reflect only services that were directly labeled as COVID-related on claims, so other pandemic-related care not explicitly coded is not included.
Detroit saw the highest total for Medicaid payments connected to COVID-19 services in Michigan for 2024, with $432,564 in claims.
Cadillac had two providers who billed Medicaid for COVID-19–related services in 2024. The most frequently used code was Immunoassay, responsible for $5,980 of the total.
On average, each Cadillac provider received $4,945 in Medicaid payments for COVID-19–related bills, which was below Michigan’s statewide average of $11,005.
During the pandemic, services specific to COVID-19 significantly contributed to Cadillac’s Medicaid spending growth.
Medicaid payments for all other services went up by $1,752,754 from 2020 to 2024, marking a 27.2% increase.
Centers for Medicare & Medicaid Services data show that combined state and federal Medicaid outlays climbed to approximately $871.7 billion for fiscal year 2023—about 18% of U.S. health expenditures—up from $613.5 billion in 2019, before the emergence of COVID-19.
The growth of around 40% in just a few years was driven mainly by expanding enrollment and more service use during and after the pandemic.
Trump administration budget legislation recently enacted has included major proposed changes to federal Medicaid funding and program structure. The “One Big Beautiful Bill Act,”, passed in 2025, is expected to reduce federal Medicaid funding by over $1 trillion over the coming decade and introduces policies such as work requirements and higher cost-sharing, which could lead to less coverage and funding for certain recipients. These measures are likely to increase financial responsibility for states and restrain the pace of federal Medicaid funding growth, while the program continues to provide health coverage to tens of millions nationwide.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $9,890 | -66.7% | $8,208,546 |
| 2023 | $29,661 | -75.8% | $8,113,393 |
| 2022 | $122,392 | -37.3% | $8,183,886 |
| 2021 | $195,057 | 106.9% | $7,785,323 |
| 2020 | $94,256 | N/A | $6,540,158 |
| 2019 | $0 | N/A | $7,246,122 |
| 2018 | $0 | N/A | $7,304,505 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $5,980 | 201 |
| 87635 | COVID Specific | $1,993 | 72 |
| U0002 | COVID Specific | $1,916 | 74 |
Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.
Details for this story come from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The original data is available here.

